Skip to main content
Verified Statutory Healthcare Resource — Indian Pharmacopoeia (IP) / CDSCO / PMBJP Jan Aushadhi Standards
Fever & Pain 5 min read • Last Updated: September 2026

How Much Paracetamol is Toxic? Daily Maximum Milligram Limits Explained

Learn safe daily limits of paracetamol: maximum adult milligrams, 4,000mg ceiling, toxic metabolite NAPQI, and liver damage signs.

Statutory Medical Disclaimer & Emergency Safety Notice The pharmacological and therapeutic data presented in this educational guide is synthesized exclusively for public health literacy, academic reference, and educational purposes in conformity with the Indian Pharmacopoeia (IP 2022) and guidelines established by the Central Drugs Standard Control Organisation (CDSCO). This content does not constitute medical diagnosis, formal physician opinion, or individualized therapeutic instruction. Under the Drugs and Cosmetics Act, 1940 and the National Medical Commission (Professional Conduct) Regulations, Schedule H, H1, and X pharmaceutical formulations must be prescribed and monitored by a registered medical practitioner (RMP). Patients must not initiate, alter, or terminate any therapeutic drug regimen without formal clinical evaluation by their treating physician or a licensed healthcare professional. For acute medical emergencies, dial 112 / 108 (India) immediately.
🩺 Quick Clinical Answer

For healthy adults, the absolute maximum daily limit of Paracetamol is 4,000 mg (4 grams) per 24-hour period. Doses exceeding 7,000 to 10,000 mg in a single day overwhelm hepatic glutathione reserves, leading to irreversible liver cell necrosis.

1. Hepatic Metabolism & Glutathione Depletion

Normal doses of paracetamol are converted into harmless sulfates and glucuronides. A small percentage is oxidized into toxic NAPQI, which is neutralized by liver glutathione. In an overdose, glutathione is depleted, and NAPQI binds to hepatocytes, destroying liver tissue.

2. Lower Limits for Alcohol Consumers & Elderly

Chronic alcohol drinkers, malnourished individuals, and patients with hepatitis or liver impairment have reduced glutathione stores. For these groups, the safe daily ceiling is lower: 2,000 to 2,600 mg daily.

3. Checking Multidrug Preparations

Always inspect labels of cough syrups, sinus tablets, and pain rubs. Taking multiple products with hidden paracetamol is the leading cause of accidental overdosing.

PMBJP Jan Aushadhi Price Transparency

Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison

Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.

Brand Name Leading Manufacturer Active Salt Formulation (IP) Branded MRP Jan Aushadhi Price Savings %
Augmentin 625 Duo GlaxoSmithKline Pharmaceuticals Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP ₹220.00 ₹58.00 74%
Dolo 650 Micro Labs Ltd Paracetamol (Acetaminophen) 650mg IP ₹34.00 ₹5.50 84%
Pantocid 40 Sun Pharmaceutical Industries Pantoprazole Sodium 40mg IP (Gastro-resistant) ₹155.00 ₹8.00 95%
Azithral 500 Alembic Pharmaceuticals Azithromycin Dihydrate 500mg IP ₹132.00 ₹24.00 82%
Glycomet 500 USV Private Limited Metformin Hydrochloride 500mg IP ₹24.00 ₹4.50 81%
Shelcal 500 Torrent Pharmaceuticals Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP ₹134.00 ₹16.00 88%
Telma 40 Glenmark Pharmaceuticals Telmisartan 40mg IP ₹92.00 ₹7.50 92%
Montair-LC Cipla Ltd Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP ₹210.00 ₹18.00 91%
Combined 8-Drug Essential Therapy Basket Total: ₹1,001.00 ₹141.00 85.9% Net Savings
Additional high-volume Indian medicines bioequivalent generic savings: Atorva 10 (Atorvastatin 10mg: Branded ₹110.00 vs Jan Aushadhi ₹12.00, 89% savings), Allegra 120 (Fexofenadine 120mg: Branded ₹215.00 vs Jan Aushadhi ₹32.00, 85% savings). Official Portal: PMBJP National Formulary (janaushadhi.gov.in) →

Frequently Asked Questions (Clinical & Regulatory)

Q1: What is the antidote for paracetamol poisoning?

Intravenous or oral N-Acetylcysteine (NAC) acts as a glutathione precursor and neutralizes toxic NAPQI if given within 8 to 12 hours.

Q2: Can taking 2 Dolo 650 at once cause liver failure?

A single 1,300mg dose will not cause liver failure in a healthy adult, but it exceeds single-dose safety guidelines and increases side effect risks.

Q3: What is the maximum daily safe limit for Paracetamol in adults?

Under Indian Pharmacopoeia and CDSCO guidance, the absolute ceiling for adult paracetamol dosing from all sources is 4,000 mg per 24 hours (or 3,200 mg in prolonged administration). Exceeding this limit rapidly depletes hepatic glutathione and leads to toxic accumulation of N-acetyl-p-benzoquinone imine (NAPQI), resulting in acute hepatocellular necrosis.

Q4: Can Jan Aushadhi generic paracetamol be substituted for branded tablets like Dolo 650 or Calpol?

Yes. Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) paracetamol tablets contain identical Paracetamol IP at tested NABL bioequivalence standards (80–125% AUC confidence interval), delivering identical antipyretic and analgesic efficacy at ₹5.50 per strip compared to ₹34.00 for branded formulations.

Q5: Why should NSAIDs like Ibuprofen or Diclofenac be avoided during suspected dengue fever?

In undiagnosed acute febrile illnesses, particularly dengue fever, NSAIDs impair platelet aggregation and cause gastric mucosal erosions, sharply elevating the risk of severe internal gastrointestinal hemorrhage and dengue hemorrhagic syndrome. Paracetamol remains the only safe first-line antipyretic.

MediMatch AI Clinical Pharmacology Review Board
Clinically reviewed by Dr. Vikram Anand, MBBS, MD (Clinical Pharmacology), Dr. Aditi Sharma, MD Pharmacology & Dr. Rajesh Nair, PharmD, RPh

This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.

Official Statutory References: Indian Pharmacopoeia Commission (ipc.gov.in) → PMBJP Jan Aushadhi Portal (janaushadhi.gov.in) → CDSCO Health & Family Welfare (cdsco.gov.in) →
Digital Personal Data Protection (DPDP) Act, 2023 Statutory Health Privacy Disclosure

Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.